Neurodevelopment and In Utero Antiretroviral Exposure of HIV-Exposed Uninfected Infants

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Pediatrics

• Publication date

  2010-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1542/peds.2009-1112PMID 20083530PMCID PMC2951128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Faculty Opinions recommendation of Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

  2010cited by this paper
• Persistent human immunodeficiency virus‐1 antigenaemia affects the expression of interleukin‐7Rα on central and effector memory CD4+ and CD8+ T cell subsets

  2008cited by this paper
• Challenges in using observational studies to evaluate adverse effects of treatment.

  2007cited by this paper
• Safety of Agents Used to Prevent Mother-to-Child Transmission of HIV

  2007cited by this paper
• In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children

  2007cited by this paper
• Neurodevelopmental Functioning in HIV-Infected Infants and Young Children Before and After the Introduction of Protease Inhibitor–Based Highly Active Antiretroviral Therapy

  2007cited by this paper
• Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother‐to‐child transmission of HIV infection

  2007cited by this paper
• Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

  2006cited by this paper
• In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts.

  2006cited by this paper
• A Prospective Controlled Study of Neurodevelopment in HIV-Uninfected Children Exposed to Combination Antiretroviral Drugs in Pregnancy

  2006cited by this paper
• Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study.

  2006cited by this paper
• Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice.

  2005cited by this paper
• Haematological parameters of HIV‐1‐uninfected infants born to HIV‐1‐infected mothers

  2005cited by this paper
• Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs.

  2004cited by this paper
• Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers

  2004cited by this paper
• High rates of behavioral problems in perinatally HIV-infected children are not linked to HIV disease.

  2003cited by this paper
• Developmental outcome of drug-exposed children through 30 months: a comparison of Bayley and Bayley-II.

  2003cited by this paper
• Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.

  2003cited by this paper
• Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.

  2003cited by this paper
• Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort

  2003cited by this paper
• Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants

  2003cited by this paper
• Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women.

  2003cited by this paper
• Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States

  2003cited by this paper
• Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants.

  2002cited by this paper
• Combination Antiretroviral Strategies for the Treatment of Pregnant HIV‐1‐Infected Women and Prevention of Perinatal HIV‐1 Transmission

  2002cited by this paper
• Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.

  2001cited by this paper
• Head growth and neurodevelopment of infants born to HIV-1–infected drug-using women

  2001cited by this paper
• Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.

  2001cited by this paper
• Drug Safety during Pregnancy and in Infants: Lack of Mortality Related to Mitochondrial Dysfunction among Perinatally HIV‐Exposed Children in Pediatric HIV Surveillance

  2000cited by this paper
• Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group.

  2000cited by this paper
• Nucleoside Exposure in the Children of HIV‐Infected Women Receiving Antiretroviral Drugs: Absence of Clear Evidence for Mitochondrial Disease in Children Who Died Before 5 Years of Age in Five United States Cohorts

  2000cited by this paper
• Early Cognitive and Motor Development Among Infants Born to Women Infected With Human Immunodeficiency Virus

  2000cited by this paper
• Lack of Definitive Severe Mitochondrial Signs and Symptoms among Deceased HIV‐Uninfected and HIV‐Indeterminate Children ≤ 5 Years of Age, Pediatric Spectrum of HIV Disease Project (PSD), USA

  2000cited by this paper
• Lack of Evidence of Mitochondrial Dysfunction in the Offspring of HIV‐Infected Women: Retrospective Review of Perinatal Exposure to Antiretroviral Drugs in the Perinatal AIDS Collaborative Transmission Study

  2000cited by this paper
• Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

  1999cited by this paper
• Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.

  1999cited by this paper
• Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine.

  1999cited by this paper
• Safety of the maternal–infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study

  1998cited by this paper
• Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys.

  1997cited by this paper
• Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group.

  1996cited by this paper
• Nonclinical toxicology studies with zidovudine: genetic toxicity tests and carcinogenicity bioassays in mice and rats.

  1996cited by this paper
• Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

  1994cited by this paper
• Maternal Drug Use in Perinatal HIV Studies: The Women and Infants Transmission Study a

  1993cited by this paper
• [In the children's hospital].

  1984cited by this paper
• Manual for the Bayley Scales of Infant Development

  1969cited by this paper

• Maternal Use of Integrase Strand Transfer Inhibitors During Pregnancy and Infant Neurodevelopment

  2025cites this paper
• Prenatal Antiretroviral Exposure and Concomitant Neurodevelopmental Problems among 5-year-old Children who are HIV-Exposed and Uninfected.

  2025cites this paper
• Neurodevelopment among children exposed to HIV and uninfected in sub‐Saharan Africa

  2023cites this paper
• Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV.

  2023cites this paper
• In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children

  2023cites this paper
• Central Nervous System and Neurodevelopmental Outcomes of HIV+ and HIV exposed children: A Mini Review of Recent Findings and Lessons Learned from the Field.

  2022cites this paper
• Neurodevelopmental outcomes of HIV/antiretroviral drug perinatally exposed uninfected children aged 3–6 years

  2022cites this paper
• No Difference in Growth Outcomes up to 24 Months of Age by Duration of Exposure to Maternal Antiretroviral Therapy Among Children Who Are HIV-Exposed and Uninfected in Malawi

  2022cites this paper
• Early academic achievement of HIV-exposed uninfected children compared to HIV-unexposed uninfected children at 5 years of age

  2021cites this paper
• El cuidado cariñoso y sensible para el desarrollo en la primera infancia. Marco para ayudar a los niños y niñas a sobrevivir y prosperar a fin de transformar la salud y el potencial humano

  2021cites this paper
• Nevirapine Pharmacokinetics in Neonates Between 25 and 32 Weeks Gestational Age for the Prevention of Mother-to-Child Transmission of HIV

  2021cites this paper
• Neurological development of children who are HIV‐exposed and uninfected

  2021cites this paper
• In utero antiretroviral exposure and sociodemographic characteristics on neurodevelopment of HIV‐exposed uninfected children versus HIV‐unexposed uninfected healthy children in Malawi

  2020cites this paper
• Neurodevelopmental and behavioural outcome of the HIV-exposed uninfected infant and child

  2020cites this paper
• Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States

  2020cites this paper
• A description of early neurodevelopment in a cohort of HIV-exposed uninfected children

  2020cites this paper
• Differential effects of antiretroviral drug toxicity in male versus female children who are HIV-exposed but uninfected.

  2020cites this paper
• Evaluating Neurodevelopmental Consequences of Perinatal Exposure to Antiretroviral Drugs: Current Challenges and New Approaches

  2019cites this paper
• HIV Viremia During Pregnancy and Neurodevelopment of HIV-Exposed Uninfected Children in the Context of Universal Antiretroviral Therapy and Breastfeeding: A Prospective Study

  2019cites this paper
• Proteomic insights into the modulation of foetal neurogenesis by the anti-retroviral efavirenz

  2019cites this paper
• Maternal Factors Associated With Infant Neurodevelopment in HIV-Exposed Uninfected Infants

  2019cites this paper
• Screening for HIV Infection in Pregnant Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2019cites this paper
• In Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV-exposed Uninfected Children in Botswana.

  2019cites this paper
• Pregnancy outcomes and effects of antiretroviral drugs in HIV-positive pregnant women: a systematic review

  2019cites this paper
• Influence of exposure and vertical transmission of HIV-1 on the neuropsychomotor development in children.

  2019cites this paper
• Perinatal HIV Infection or Exposure Is Associated With Low N-Acetylaspartate and Glutamate in Basal Ganglia at Age 9 but Not 7 Years

  2018cites this paper
• Neurodevelopmental outcome of HIV‐exposed but uninfected infants in the Mother and Infants Health Study, Cape Town, South Africa

  2018cites this paper
• Growth and Development Status in the First Two Years of Uninfected Children Born From HIV Positive Mothers

  2018cites this paper
• Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, Botswana

  2018cites this paper
• Neurodevelopment in Young Children Born to HIV-Infected Mothers: A Meta-analysis

  2018cites this paper
• Concurrent validity between instruments of assessment of motor development in infants exposed to HIV.

  2018cites this paper
• In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana

  2018cites this paper
• Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa

  2018cites this paper
• Feeding difficulties in infants with unrepaired cleft lip and palate and HIV-exposure

  2018cites this paper
• Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015

  2018cites this paper
• Mitochondrial Toxicity in Children and Adolescents Exposed to Antiretroviral Therapy

  2018cites this paper
• Developmental delay and behavioral disorders in 59 HIV-exposed uninfected infants.

  2017cites this paper
• Quality of Caregiving is Positively Associated With Neurodevelopment During the First Year of Life Among HIV-Exposed Uninfected Children in Uganda

  2017cites this paper
• Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children

  2017cites this paper
• Changes in Fertility at the Population Level in the Era of ART in Rural Malawi

  2017cites this paper
• Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months

  2017cites this paper
• Evaluation of motor and cognitive development among infants exposed to HIV.

  2017cites this paper
• Development assessment of HIV exposed children aged 6–18 months: a cohort study from North India

  2017cites this paper
• Longitudinal development of cognitive, visuomotor and adaptive behavior skills in HIV uninfected children, aged 3–5 years of age, exposed pre- and perinatally to anti-retroviral medications

  2017cites this paper
• Infection de l’enfant par le virus de l’immunodéficience humaine de type 1

  2017cites this paper
• Disclosing in utero HIV/ARV exposure to the HIV-exposed uninfected adolescent: is it necessary?

  2016cites this paper
• The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs

  2016cites this paper
• Surveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges

  2016cites this paper
• Auditory Alterations in Children Infected by Human Immunodeficiency Virus Verified Through Auditory Processing Test

  2016cites this paper
• Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean

  2016cites this paper
• Neurodevelopmental delay in pediatric HIV/AIDS: current perspectives

  2016cites this paper
• Estructuras de fábrica: enfoques «antiguos» y «modernos» para fenómenos muy locales

  2016cites this paper
• Neurodevelopmental delay in pediatric HIV/AIDS: current perspectives

  2016cites this paper
• Perinatally acquired HIV infection: Long-term neuropsychological consequences and challenges ahead

  2015cites this paper
• Prise en charge du nouveau-né de mère infectée par le VIH : évaluation des pratiques de prescription de névirapine chez le nouveau-né

  2015cites this paper
• Correlates of Age at Attainment of Developmental Milestones in HIV-infected Infants Receiving Early Antiretroviral Therapy

  2015cites this paper
• Brain Imaging and Neurodevelopment in HIV-uninfected Thai Children Born to HIV-infected Mothers

  2015cites this paper
• The neurodevelopment of HIV-infected infants on HAART compared to HIV-exposed but uninfected infants

  2014cites this paper
• Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding

  2014cites this paper
• Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV

  2014cites this paper
• Safety of In Utero and Neonatal Antiretroviral Exposure: Cognitive and Academic Outcomes in HIV-exposed, Uninfected Children 5–13 Years of Age

  2014cites this paper
• RISK FACTORS OF HIV-1 VERTICAL TRANSMISSION (VT) AND THE INFLUENCE OF ANTIRETROVIRAL THERAPY (ART) IN PREGNANCY OUTCOME

  2014cites this paper
• HIV-exposed infants: rethinking care for a lifelong condition

  2013cites this paper
• [Impact of maternal HIV status on family constructions and the infant's relational environment during the perinatal period].

  2013cites this paper
• Reproductive Health Decision-Making in Perinatally HIV-Infected Adolescents and Young Adults

  2013cites this paper
• Working Group of the Interagency Task Team on the Prevention and Treatment of HIV infection in Pregnant Women, Mothers and Children

  2013cites this paper
• Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child.

  2013cites this paper
• Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B+ approach.

  2013cites this paper
• Impact de la séropositivité maternelle au VIH sur les constructions familiales et sur l’environnement relationnel de l’enfant en période périnatale

  2013cites this paper
• Family Adversity and Autonomic Reactivity Association With Immune Changes in HIV-Affected School Children

  2013influential citation
• Safety of Perinatal Exposure to Antiretroviral Medications: Developmental Outcomes in Infants

  2013cites this paper
• Neurodevelopment in Children Born to HIV-Infected Mothers by Infection and Treatment Status

  2012cites this paper
• [Recommendations issued by the Spanish Society of Pediatric Infectious Diseases for the follow-up of the child exposed to the human immunodeficiency virus and to antiretroviral drugs during pregnancy and the neonatal period].

  2012cites this paper
• Human immunodeficiency virus and the central nervous system.

  2012cites this paper
• Screening for HIV in Pregnant Women: Systematic Review to Update the 2005 U.S. Preventive Services Task Force Recommendation

  2012cites this paper
• Zidovudine Exposure in HIV-1 Infected Tanzanian Women Increases Mitochondrial DNA Levels in Placenta and Umbilical Cords

  2012cites this paper
• Distinct Disadvantage : A Review of Children Under 8 and the HIV / AIDS Epidemic Prof

  2012cites this paper
• Measuring infant memory: Utility of the visual paired-comparison test paradigm for studies in developmental neurotoxicology.

  2012cites this paper
• Neurodevelopmental status of HIV-exposed but uninfected children: A pilot study

  2012cites this paper
• Serum Dioxins and Polychlorinated Biphenyls Are Associated With Growth Among Russian Boys

  2011cites this paper
• Antiretroviral Drugs for Preventing Mother-to-Child Transmission of HIV: A Review of Potential Effects on HIV-Exposed but Uninfected Children

  2011cites this paper
• Potential for childhood lead poisoning in the inner cities of Australia due to exposure to lead in soil dust.

  2011cites this paper
• Vigilância do desenvolvimento neuropsicomotor de crianças de um programa DST/AIDS

  2011cites this paper
• Newborn hearing screening in infants born to HIV-seropositive mothers.

  2011cites this paper
• Estimation of leaded (Pb) gasoline's continuing material and health impacts on 90 US urbanized areas.

  2011cites this paper
• Asking the right questions: developing evidence-based strategies for treating HIV in women and children

  2011cites this paper
• Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction

  2010cites this paper
• Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs).

  2010cites this paper
• Denver Developmental Screening Test (DDST) survey and degree of malnutrition among children born to HIV infected mothers under the Prevention of Mother to-Child-Transmission (PMTCT) Program.

  2010cites this paper
• Prevention of vertical transmission of HIV-1 in resource-limited settings

  2010cites this paper
• NeuroAIDS in Africa

  2010cites this paper
• Review NeuroAIDS in Afr ica

  2010cites this paper
• Vertical transmission of HIV in Belgium: a 1986–2002 retrospective analysis

  2008cites this paper
• Neurodevelopment in Children Born to Hiv-infected Mothers by Infection and Treatment Status

  year unknowncites this paper